Siva Vanapalli, PhD

CEO
NemaLife Inc

Poster(s):

• (LB01-21-25) A Bio-IntelligenceTM Platform for High Throughput Discovery and In Vivo Validation of Synergistic Bioactives
  Saturday, May 31, 2025

  11:45 AM - 12:45 PM ET

• (LB01-22-25) Zero-G IngredientsTM: A New Class of Bioactives Supporting Human Health Based on Testing in the Extreme Environment of the International Space Station
  Saturday, May 31, 2025

  12:45 PM - 1:45 PM ET

• (P26-018-25) Evaluation of Reducose® in C. elegans: Exploring Multifaceted Health Benefits Using an AI-Assisted Microfluidic Platform
  Monday, June 2, 2025

  12:45 PM - 1:45 PM ET